|
|
Clinical effect of low dose Glucocorticoid combined with Theophylline in treating bronchial asthma |
CHEN Xiao-yun TANG Xiao-xiao |
The Second Department of Respiratory,Zhongshan Hospital of Affiliated to Dalian University,Liaoning Province,Dalian 116001,China |
|
|
Abstract Objective To explore the clinical effect of low-dose glucocorticoid(GC)combined with Theophylline in the treatment of bronchial asthma.Methods A total of 80 cases with bronchial asthma admitted in Zhongshan Hospital of Affiliated to Dalian University from April 2018 to April 2019 were selected and divided into observation group and control group,40 cases in each group.The observation group was treated with inhaled beclomethasone dipropionate 250 μg/ twice a day combined with oral sustained-release Theophylline,while the control group was treated with inhaled beclomethasone dipropionate 500 μg/ twice a day.After one course of treatment,the changes of inflammatory indicators were compared between the two groups.The results of asthma control test were the changes of standard(ACT)scores during treatment.The recurrence and hospitalization due to acute asthma attack,and the occurrence of adverse reactions during treatment was compared between the two groups.Results The levels of tumor necrosis factor-α(TNFα)and high-sensitivity C-reactive protein(hs-CRP)in the inflammatory indexes of the observation group were lower than those of the control group,the differences were statistically significant(P<0.05).The ACT score of the observation group was higher than that of the control group at the same time,the difference was statistically significant(P<0.05).One week after treatment and one month after treatment.the total proportion of skin pruritus,water and sodium retention,abnormal blood glucose and so on in the observation group during treatment were lower than those of the control group,the differences were statistically significant(P<0.05).After one year of follow-up,the recurrence and hospitalization times due to acute asthma attack in the observation group were lower than those of the control group,the differences were statistically significant(P<0.05).Conclusion For bronchial asthma,theophylline combined with lowdose GC can effectively reduce inflammatory reaction and improve clinical symptoms with few adverse reactions,which is of great significance for reducing acute attack of asthma.
|
Received: 16 June 2020
|
|
|
|
[5] |
柯楠.茶碱缓释片联合布地奈德福莫特罗粉吸入剂治疗中度支气管哮喘的临床效果[J].河南医学研究,2020,29(7):1283-1284.
|
[6] |
吴刚.多索茶碱联合异丙托溴铵治疗支气管哮喘急性发作疗效探讨[J].系统医学,2020,5(3):7-9.
|
[1] |
尚小景.多索茶碱与氨茶碱治疗老年支气管哮喘急性发作的效果比较[J].临床医学,2020,40(5):118-120.
|
[2] |
田永光.多索茶碱联合沙丁胺醇对支气管哮喘患者血清TNF-α、HMGB1 水平的影响[J].慢性病学杂志,2020,21(4):606-607,610.
|
[3] |
刘占诺.甲氧那明联合多索茶碱对咳嗽变异性哮喘的治疗效果[J].河南医学研究,2020,29(8):1442-1443.
|
[4] |
杜伟.氨茶碱与多索茶碱在支气管哮喘治疗中疗效比较[J].中国现代药物应用,2020,14(5):148-149.
|
[8] |
林建华.射干麻黄汤加减联合多索茶碱治疗支气管哮喘的临床效果分析[J].中国现代药物应用,2020,14(1):202-204.
|
[9] |
苏秋.氨茶碱和多索茶碱治疗支气管哮喘效果比较[J].临床合理用药杂志,2019,12(34):80-81.
|
[10] |
薛兴荣,赵龙,王军,等.二羟丙茶碱联合甲泼尼龙治疗支气管哮喘对症状及FVC、FEV1的改善作用[J].现代医学与健康研究电子杂志,2019,3(20):55-57.
|
[7] |
林春华.茶碱控释片在急性老年人哮喘治疗中的应用效果[J].深圳中西医结合杂志,2020,30(1):172-173.
|
[11] |
刘娟.布地奈德雾化吸入联合多索茶碱在小儿支气管哮喘临床治疗中的应用价值[J].哈尔滨医药,2019,39(5):436-437.
|
[12] |
龙俊国.氨茶碱和多索茶碱治疗支气管哮喘的疗效比较[J].临床合理用药杂志,2019,12(29):39-40.
|
[13] |
刘云云.吸入糖皮质激素联合茶碱与联合长效β2 受体激动剂对哮喘的疗效评价[J].全科口腔医学电子杂志,2019,6(31):194-195.
|
[14] |
孙俊丽.沙美特罗替卡松粉联合多索茶碱及复方甲氧那明治疗支气管哮喘急性发作期疗效分析[J].湖北科技学院学报(医学版),2019,33(4):302-304.
|
[15] |
黄清莲,许鲁宁.比较吸入糖皮质激素(ICS)联合茶碱与联合长效β2受体激动剂(LABA)治疗哮喘的效果[J].海峡药学,2019,31(8):168-169.
|
[16] |
任文珍.氨茶碱与多索茶碱在治疗支气管哮喘过程中疗效及不良反应比较[J].中国农村卫生,2019,11(14):86,89.
|
[17] |
李红,亓占中.多索茶碱与复方异丙托溴铵治疗支气管哮喘的疗效比较[J].西南国防医药,2019,29(7):758-760.
|
[18] |
李俭平.多索茶碱联合异丙托溴铵治疗支气管哮喘急性发作的疗效[J].中国药物经济学,2019,14(6):93-95.
|
|
|
|